Metastatic/Stage IVB
January Is National Cervical Cancer Awareness Month
(01/02/2009)
As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer information throughout the year.
Cancer Consultants Offers Free Subscriptions to Women&Cancer Magazine
(12/01/2008)
Women&Cancer is the premier women’s health and wellness magazine. By covering all health and wellness issues with an emphasis on cancer prevention, early detection, management, and survivorship, Women&Cancer empowers women with regard to their own health and recognizes the unique role of women in the overall health of their family and friends.
Updates in the Management of Gynecologic Cancers
(05/27/2008)
A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists
Cervical Cancer Survivors Face Risk of Second Cancers
(04/27/2007)
According to the results of a study presented at the 2007 annual meeting of the American Association for Cancer Research (AACR), the risk of a second cancer among women with a history of cervical cancer is higher than the cancer risk in the general population.
Hycamtin® Approved for Advanced Cervical Cancer
(06/26/2006)
According to a press release from GlaxoSmithKline, Hycamtin® (topotecan) was recently approved by the U.S. Food and Drug Administration (FDA) for a new use—the treatment of stage IVB, recurrent, or persistent cervical cancer, when given in combination with Platinol® (cisplatin).
▪ More...
Recurrent
Avastin® Shows Promise in Treatment of Cervical Cancer
(03/02/2009)
According to the results of a Phase II clinical trial, the targeted therapy Avastin® (bevacizumab) warrants further investigation in the treatment of persistent or recurrent squamous cell carcinoma of the cervix. These results were published in the Journal of Clinical Oncology.
January Is National Cervical Cancer Awareness Month
(01/02/2009)
As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer information throughout the year.
Cancer Consultants Offers Free Subscriptions to Women&Cancer Magazine
(12/01/2008)
Women&Cancer is the premier women’s health and wellness magazine. By covering all health and wellness issues with an emphasis on cancer prevention, early detection, management, and survivorship, Women&Cancer empowers women with regard to their own health and recognizes the unique role of women in the overall health of their family and friends.
Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers
(03/17/2008)
The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective as and more convenient than second-day administration. These results were recently reported at the 2008 annual Society of Gynecologic Oncologists meeting.
Cervical Cancer Survivors Face Long-term Risk of Second Cancers
(11/01/2007)
According to the results of a study published in the Journal of the National Cancer Institute, cervical cancer survivors have an increased risk of later developing other types of cancer, particularly if their cervical cancer was treated with radiation therapy. This increased risk persists for more than 40 years after the cervical cancer diagnosis.
▪ More...
Screening/Prevention
ACOG Updates Cervical Cancer Screening Guidelines
(11/20/2009)
The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.
Second HPV Vaccine Approved in U.S.
(10/16/2009)
The U.S. Food and Drug Administration has approved Cervarix®, a vaccine against two high-risk types of human papillomavirus (HPV), for prevention of cervical cancer and cervical precancers. This is the second HPV vaccine to be approved in the United States.
FDA Advisory Committee Backs Second Cervical Cancer Vaccine
(09/11/2009)
A U.S. Food and Drug Administration (FDA) advisory committee has concluded that Cervarix®—a vaccine against two high-risk types of human papillomavirus (HPV)—is safe and effective for the prevention of cervical cancer.
Immunosuppression Increases Risk of HPV-related Cancers in AIDS Patients
(08/20/2009)
The risk of HPV-related cancers is elevated among AIDS patients. This risk continues to increase as patients’ immune systems become more compromised, according to the results of a study published in the Journal of the National Cancer Institute.
Pap Screening May Be Unnecessary for Teens
(08/06/2009)
American women undergo cervical cancer screening at a younger age than their European counterparts, but this early screening may be unnecessary and possibly even harmful, according to three studies recently published in the British Medical Journal.
▪ More...
Stage I
Sentinel Node Biopsy Is a Minimally-invasive, Effective Method for Determining Spread of Cervical Cancer
(06/09/2009)
The majority of women with cervical cancer can safely undergo sentinel node biopsy instead of full pelvic lymph node dissection to determine the spread of their disease, thereby avoiding the complications associated with the more invasive procedure, according to the results of a study presented at the 2009 annual meeting of the American Society of Clinical Oncology in Orlando, Florida.
January Is National Cervical Cancer Awareness Month
(01/02/2009)
As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer information throughout the year.
Cancer Consultants Offers Free Subscriptions to Women&Cancer Magazine
(12/01/2008)
Women&Cancer is the premier women’s health and wellness magazine. By covering all health and wellness issues with an emphasis on cancer prevention, early detection, management, and survivorship, Women&Cancer empowers women with regard to their own health and recognizes the unique role of women in the overall health of their family and friends.
Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer
(11/18/2008)
Robotically-assisted hysterectomy (RAH) in patients with early-stage cervical cancer is at least as effective as traditional open radical hysterectomy (ORH) and produces fewer complications, according to the results of a study published in the October 2008 issue of the American Journal of Obstetrics and Gynecology.
Updates in the Management of Gynecologic Cancers
(05/27/2008)
A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists
▪ More...
Stages II-IVA
Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer
(06/08/2009)
The combination of Gemzar® (gemcitabine), Platinol® (cisplatin), and concurrent radiation significantly improves survival over single-agent Platinol and radiation in women with Stage IIB-IVA cervical cancer, according to the results of a study presented at the 2009 annual meeting of the American Society of Clinical Oncology in Orlando, Florida.
January Is National Cervical Cancer Awareness Month
(01/02/2009)
As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer information throughout the year.
Cancer Consultants Offers Free Subscriptions to Women&Cancer Magazine
(12/01/2008)
Women&Cancer is the premier women’s health and wellness magazine. By covering all health and wellness issues with an emphasis on cancer prevention, early detection, management, and survivorship, Women&Cancer empowers women with regard to their own health and recognizes the unique role of women in the overall health of their family and friends.
Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer
(11/18/2008)
Robotically-assisted hysterectomy (RAH) in patients with early-stage cervical cancer is at least as effective as traditional open radical hysterectomy (ORH) and produces fewer complications, according to the results of a study published in the October 2008 issue of the American Journal of Obstetrics and Gynecology.
Updates in the Management of Gynecologic Cancers
(05/27/2008)
A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists
▪ More...